Reconciling human smoking behavior and machine smoking patterns: Implications for understanding smoking behavior and the impact on laboratory studies

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 12, 2009, Pages 3305-3320

  Marian, Catalin ^a   O'Connor, Richard J ^b   Djordjevic, Mirjana V ^c   Rees, Vaughan W ^d   Hatsukami, Dorothy K ^e   Shields, Peter G ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; NICOTINE; TAR;

ANALYTICAL PARAMETERS; BREATH HOLDING; CIGARETTE SMOKING; HUMAN; LABORATORY TEST; MACHINE; PRIORITY JOURNAL; REVIEW; SMOKING MACHINE; TOBACCO INDUSTRY;

BEHAVIOR, ADDICTIVE; BIOLOGICAL AVAILABILITY; HUMANS; RESEARCH; SMOKING; TOBACCO USE DISORDER;

EID: 73449127381     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-1014     Document Type: Review

References (172)

1. Warner KE. Tobacco harm reduction: promise and perils. Nicotine Tob Res 2002;4 Suppl 2:S61-71.
2. Britton J. Smokeless tobacco: friend or foe? Addiction 2003;98: 1197-207.
3. Ramstrom L. Snus: part of the problem or part of the solution? Addiction 2003;98:1198-9.
4. Fagerstrom KO, Schildt EB. Should the European Union lift the ban on snus? Evidence from the Swedish experience. Addiction 2003;98: 1191-5.
5. Pierce JP. Harm reduction or harm maintenance. Nicotine Tob Res 2002;4:S53-4.
6. Fox BJ, Cohen JE. Tobacco harm reduction: a call to address the ethical dilemmas. Nicotine Tob Res 2002;4:S81-7.
7. Hatsukami DK, Slade J, Benowitz NL, et al. Reducing tobacco harm: research challenges and issues. Nicotine Tob Res 2002;4 Suppl 2: S89-101.
8. Gartner CE, Hall WD, Chapman S, Freeman B. Should the health community promote smokeless tobacco (snus) as a harm reduction measure? PLoS Med 2007;4:e185.
9. Foulds J, Kozlowski L. Snus-what should the public-health response be? Lancet 2007;369:1976-8.
10. WHO Study Group on Tobacco Product Regulation Report on the Scientific Basis of Tobacco Product Regulation. WHO Technical Report Series, no. 951; 2008, Report No.: 951.
11. Institute of Medicine Committee to Assess the Science Base for Tobacco Harm Reduction and Board on Health Promotion and Disease Prevention. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. Washington, DC: National Academy Press; 2001.
12. Stratton K, Shetty P, Wallace R, Bondurant S. Products for tobacco exposure reduction. Clearing the SMOKE: Assessing the Science Base for Tobacco Harm Reduction. pp. 82-92: National Academy Press (Institute of Medicine); 2001.
13. National Cancer Institute. Risks Associated with Smoking Cigarettes with Low Machine-Measured Yields of Tar and Nicotine. Smoking and Tobacco Control Monograph No. 13 2001. U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, NIH Pub No.02-5074. Ref Type: Serial (Book Monograph).
14. Cohen JB. Smokers' knowledge and understanding of advertised tar numbers: health policy implications. Am J Public Health 1996;86: 18-24.
15. US. Department of Health and Human Services. Reducing the Health Cunsequences of Smoking: 25 Years of Progress. 1989, Report No.: DHHS Publication No. (CDC) 89-8411.
16. US. Department of Health and Human Services Public Health Service Office on Smoking and Health. The Health Consequences of Smoking: the Changing Cigarette, a report of the Surgeon General. 1981.
17. United States District Court for the District of Columbia. Final Opinion on U S. Department of Justice v. Philip Morris Inc, et al. Civil Action No. 99-2496. 2006.
18. United States Court of Appeals. Unanimous Opinion on U S. Department of Justice v. Philip Morris Inc. et al., No. 99cv02496. 2009.
19. Stellman SD, Muscat JE, Hoffmann D, Wynder EL. Impact of filter cigarette smoking on lung cancer histology. Prev Med 1997;26:451-6.
20. Kozlowski LT, Mehta NY, Sweeney CT, et al. Filter ventilation and nicotine content of tobacco in cigarettes from Canada, the United Kingdom, and the United States. Tob Control 1998;7:369-75.
21. Kozlowski LT, Rickert WS, Robinson JC, Grunberg NE. Have tar and nicotine yields of cigarettes changed? Science 1980;209:1550-1.
22. Benowitz NL, Hall SM, Herning RI, et al. Smokers of low-yield cigarettes do not consume less nicotine. N Engl J Med 1983;309: 139-42.
23. Benowitz NL. Compensatory Smoking of Low-Yield Cigarettes. In: US. Department of Health and Human Services NNCI , editor. Smoking and tobacco control monograph no. 13. Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine. Bethesda, MD: US Department of Health and Human Services NIH, National Cancer Institute; 2001, p. 39-63, Ref Type: Serial (Book Monograph).
24. Scherer G, Engl J, Urban M, et al. Relationship between machinederived smoke yields and biomarkers in cigarette smokers in Germany. Regul Toxicol Pharmacol 2007;47:171-83.
25. Mendes P, Kapur S, Wang J, Feng S, Roethig H. A randomized, controlled exposure study in adult smokers of full flavor Marlboro cigarettes switching to Marlboro Lights or Marlboro Ultra Lights cigarettes. Regul Toxicol Pharmacol 2008;51:295-305.
26. Hecht SS, Murphy SE, Carmella SG, et al. Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes. Cancer Epidemiol Biomarkers Prev 2005;14:693-8.
27. Thun MJ, Burns DM. Health impact of "reduced yield" cigarettes: a critical assessment of the epidemiological evidence. Tob Control 2001;10 Suppl 1:i4-11.
28. Burns DM, Dybing E, Gray N, et al. Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal. Tob Control 2008;17:132-41.
29. Hammond D, Wiebel F, Kozlowski LT, et al. Revising the machine smoking regime for cigarette emissions: implications for tobacco control policy. Tob Control 2007;16:8-14.
30. Hammond D, Fong G, Cummings KM, et al. Cigarette yields and human exposure: a comparison of alternative testing regimens. Cancer Epidemiol Biomark Prev 2006;15:1495-501.
31. National Cancer Institute. The FTC Cigarette Test Method for Detemining Tar, Nicotine, and Carbon Monoxide Yields of U S. Cigarettes. 1996, USDepartment of Health and Human Services, National Institutes of Health, National Cancer Institute, NIH Pub No.96-4028. Ref Type: Serial (Book Monograph).
32. Johnson MD, Schilz J, Djordjevic MV, Rice JR, Shields PG. Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco.Cancer Epidemiol Biomarkers Prev 2009;18:3263-304.
33. Pfyl B. The determination of nicotine in tobacco smoke II. Z Unters Lebensm 1933;6:501-9.
34. Bradford JA, Harlan WR, Hanmer HR. Nature of cigarette smoke. Technic of experimental smoking. Industrial and Engineering Chemistry 1936;28:836-9.
35. Adam T, Baker RR, Zimmermann R. Investigation, by single photon ionisation (SPI)-time-of-flight mass spectrometry (TOFMS), of the effect of different cigarette-lighting devices on the chemical composition of the first cigarette puff. Anal Bioanal Chem 2007; 387:575-84.
36. Peeler CL, Butters GR. Re: It's time for a change: cigarette smokers deserve meaningful information about their cigarettes. J Natl Cancer Inst 2000;92:842-3.
37. Bialous SA, Yach D. Whose standard is it, anyway? How the tobacco industry determines the International Organization for Standardization (ISO) standards for tobacco and tobacco products. Tob Control 2001;10:96-104.
38. Baker RR, Massey ED, Smith G. An overview of the effects of tobacco ingredients on smoke chemistry and toxicity. Food Chem Toxicol 2004; 42 Suppl:S53-83.
39. Wynder EL, Graham EA. Tobacco smoking as a possible etiologic factor in bronchogenic carcinoma. JAMA 1950;143:329-36.
40. Doll R, Hill AB. Smoking and carcinoma of the lung: preliminary report. Br Med J 1950;2:739-48.
41. Federal Trade Commission. News Release. FTC to Begin Cigarette Testing. Legacy Tobacco Documents Library; 1967.
42. Ogg CL. Determination of particulate matter and alkaloids (as nicotine) in cigarette smoke. Journal of the Association of Official Agricultural Chemists 1964;47:356-62.
43. CORESTARecommended Method N° 22. Routine Analytical Cigarette-Smoking Machine Specifications, Definitions and Standard Conditions. pp. 124-40: CORESTA Information Bulletin; 1991.
44. International Organisation for Standardisation. Routine Analytical Cigarette Smoking Machine. Specification for the Machine and Auxiliary Equipment; ISO 3308. First Edition; 1977.
45. Guillerm R, Radziszewski E. Analysis of smoking pattern including intake of carbon monoxide and influences of changes in cigarette design. In: Thornton RE, editor. Smoking behaviour. Edinburgh, London and New York: Churchill Livingstone; 1978.
46. International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risks of Chemicals to Humans: Tobacco Smoking and Involuntary Smoking. [83]; 2004, Ref Type: Serial (Book Monograph).
47. Frederiksen LW, Frazier M. Temporal distribution of smoking. Addict Behav 1977;2:187-94.
48. Frederiksen LW, Miller PM, Peterson GL. Topographical components of smoking behavior. Addict Behav 1977;2:55-61.
49. Hatsukami D, Morgan SF, Pickens RW, Hughes JR. Smoking topography in a nonlaboratory environment. Int J Addict 1987;22: 719-25.
50. Hatsukami DK, Pickens RW, Svikis DS, Hughes JR. Smoking topography and nicotine blood levels. Addict Behav 1988;13:91-5.
51. Nemeth-Coslett R, Griffiths RR. Determinants of puff duration in cigarette smokers: I. Pharmacol Biochem Behav 1984;20:965-71.
52. Battig K, Buzzi R, Nil R. Smoke yield of cigarettes and puffing behavior in men and women. Psychopharmacology (Berl) 1982;76:139-48.
53. Lee E, Malson J,Waters A, Moolchan E, Pickworth W. Smoking topography: reliability and validity in dependent smokers. Nicotine Tob Res 2003;5:673-9.
54. Djordjevic MV, Stellman SD, Zang E. Doses of nicotine and lung carcinogens delivered to cigarette smokers [see comments]. J Natl Cancer Inst 2000;19:106-11.
55. Melikian AA, Djordjevic MV, Chen S, Richie J, Jr., Stellman SD. Effect of delivered dosage of cigarette smoke toxins on the levels of urinary biomarkers of exposure. Cancer Epidemiol Biomarkers Prev 2007;16: 1408-15.
56. Puustinen P, Olkkonen H, Kolonen S, Tuomisto J. Microcomputeraided measurement of puff parameters during smoking of low- and medium-tar cigarettes. Scand J Clin Lab Invest 1987;47:655-60.
57. Puustinen P, Olkkonen H, Kolonen S, Tuomisto J. Microcomputer assisted measurement of inhalation parameters during smoking. Arch Toxicol Suppl 1986;9:111-4.
58. Djordjevic MV, Fan J, Ferguson S, Hoffmann D. Self-regulation of smoking intensity. Smoke yields of the low-nicotine, low-'tar' cigarettes. Carcinogenesis 1995;16:2015-21.
59. Hofer I, Nil R, Battig K. Nicotine yield as determinant of smoke exposure indicators and puffing behavior. Pharmacol Biochem Behav 1991; 40:139-49.
60. Ahijevych K, Gillespie J, Demirci M, Jagadeesh J. Menthol and nonmenthol cigarettes and smoke exposure in black and white women. Pharmacol Biochem Behav 1996;53:355-60.
61. Zacny JP, Stitzer ML, Brown FJ, Yingling JE, Griffiths RR. Human cigarette smoking: effects of puff and inhalation parameters on smoke exposure. J Pharmacol Exp Ther 1987;240:554-64.
62. Ossip-Klein DJ, Martin JE, Lomax BD, Prue DM, Davis CJ. Assessment of smoking topography generalization across laboratory, clinical, and naturalistic settings. Addict Behav 1983;8:11-7.
63. Sutton SR, Russell MA, Iyer R, Feyerabend C, Saloojee Y. Relationship between cigarette yields, puffing patterns, and smoke intake: evidence for tar compensation? Br Med J (Clin Res Ed) 1982;285:600-3.
64. Adams PI. Measurements on Puffs Taken by Human Smokers [Abstract]. 1966.
65. Adams PI. Changes in Personal Smoking Habits brought about by changes in cigarette smoke yields. pp. 102-8Tokyo: Japan Tobacco and Salt Public Corporation; 1976.
66. Creighton DE, Noble MJ, Whewell RT. Instruments to measure, record, and duplicate human smoking patterns. In: Thornton RE, editor. Smoking Behaviour - Physiological and Psychological Influences. Edinburgh, London and New York: Churchill Livingstone; 1978, p. 277-88.
67. O'Connor RJ, Ashare RL, Cummings KM, Hawk LW, Jr. Comparing smoking behaviors and exposures from flavored and unflavored cigarettes. Addict Behav 2007;32:869-74.
68. Pickens R, Gust S, Catchings P, Svikis D. Measurement of some topographical aspects of smoking in the natural environment. In: Grabowski J, Bell C, editors. Monograph 48: Measurement in the Analysis and Treatment of Smoking Behavior.Washington, DC: National Institute on Drug Abuse Research; 1983, p. 62-73, Ref Type: Serial (Book Monograph).
69. Henningfield JE, Yingling J, Griffiths RR, Pickens R. An inexpensive portable device for measuring puffing behavior by cigarette smokers. Pharmacol Biochem Behav 1980;12:811-3.
70. Melikian AA, Djordjevic MV, Hosey J, et al. Gender differences relative to smoking behavior and emissions of toxins from mainstream cigarette smoke. Nicotine Tob Res 2007;9:377-87.
71. Eissenberg T, Adams C, Riggins EC, Likness M, III. Smokers' sex and the effects of tobacco cigarettes: subject-rated and physiological measures. Nicotine Tob Res 1999;1:317-24.
72. Buchhalter AR, Eissenberg T. Preliminary evaluation of a novel smoking system: effects on subjective and physiological measures and on smoking behavior. Nicotine Tob Res 2000;2:39-43.
73. Buchhalter AR, Schrinel L, Eissenberg T. Withdrawal-suppressing effects of a novel smoking system: comparison with own brand, not own brand, and de-nicotinized cigarettes. Nicotine Tob Res 2001;3: 111-8.
74. Breland AB, Buchhalter AR, Evans SE, Eissenberg T. Evaluating acute effects of potential reduced-exposure products for smokers: clinical laboratory methodology. Nicotine Tob Res 2002;4 Suppl 2:S131-40.
75. Hughes JR, Hecht SS, Carmella SG, Murphy SE, Callas P. Smoking behaviour and toxin exposure during six weeks use of a potential reduced exposure product: Omni. Tob Control 2004;13:175-9.
76. Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM. Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls. Drug Alcohol Depend 2005;80:259-65.
77. Franken FH, Pickworth WB, Epstein DH, Moolchan ET. Smoking rates and topography predict adolescent smoking cessation following treatment with nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev 2006;15:154-7.
78. Strasser AA, Malaiyandi V, Hoffmann E, Tyndale RF, Lerman C. An association of CYP2A6 genotype and smoking topography. Nicotine Tob Res 2007;9:511-8.
79. Rees VW,Wayne GF, Connolly GN. Puffing style and human exposure minimally altered by switching to a carbon-filtered cigarette. Cancer Epidemiol Biomarkers Prev 2008;17:2995-3003.
80. Grainge M, Shahab L, Hammond D, O'Connor R, McNeill A. First cigarette on waking and time of day as predictors of puffing behaviour in UK adult smokers. Drug Alcohol Depend 2009;-PM:19264427.
81. Djordjevic MV, Hoffmann D, Hoffmann I. Nicotine regulates smoking patterns. Prev Med 1997;26:435-40.
82. Hammond D, Fong GT, Cummings KM, Hyland A. Smoking topography, brand switching, and nicotine delivery: results from an in vivo study. Cancer Epidemiol Biomarkers Prev 2005;14:1370-5.
83. Blank MD, Disharoon S, Eissenberg T. Comparison of methods for measurement of smoking behavior: mouthpiece-based computerized devices versus direct observation. Nicotine Tob Res 2009;11:896-903.
84. Evans SE, Buchhalter AR, Breland A, Kleykamp BA, Eissenberg T. Ambulatory puff topography measurement: A validation study. New Orleans, LA; 2003.
85. Gust SW, Pickens RW, Pechacek TF. Relation of puff volume to other topographical measures of smoking. Addict Behav 1983;8:115-9.
86. Guyatt AR, Kirkham AJ, Baldry AG, Dixon M, Cumming G. How does puffing behavior alter during the smoking of a single cigarette? Pharmacol Biochem Behav 1989;33:189-95.
87. Ahijevych K, Gillespie J. Nicotine dependence and smoking topography among black and white women. Res Nurs Health 1997;20:505-14.
88. National Cancer Institute Expert Committee. The FTC cigarette test method for determining, tar, nicotine and carbon monoxide yields of U.S. cigarettes. [Monograph No. 7]. U.S. Department of Health and Human Services National Cancer Institute; 1996, Ref Type: Serial (Book Monograph).
89. Hammond D, Collishaw NE, Callard C. Secret science: tobacco industry research on smoking behaviour and cigarette toxicity. Lancet 2006; 367:781-7.
90. Kozlowski LT, O'Connor RJ. Cigarette filter ventilation is a defective design because of misleading taste, bigger puffs, and blocked vents. Tob Control 2002;11 Suppl 1:I40-50.
91. Kozlowski LT, O'Connor RJ. Official cigarette tar tests are misleading: use a two-stage, compensating test. Lancet 2000;355:2159-61.
92. Assaf AR, Parker D, Lapane KL, Carleton McKenneyJL. Are there gender differences in self-reported smoking practices? Correlation with thiocyanate and cotinine levels in smokers and nonsmokers from the Pawtucket Heart Health Program. J Womens Health (Larchmt) 2002;11:899-906.
93. Thun MJ, Heath CW, Jr. Changes in mortality from smoking in two American Cancer Society prospective studies since 1959. Prev Med 1997;26:422-6.
94. Kandel DB, Chen K. Extent of smoking and nicotine dependence in the United States: 1991-1993. Nicotine Tob Res 2000;2:263-74.
95. Etter JF, Vu DT, Perneger TV. Saliva cotinine levels in smokers and nonsmokers. Am J Epidemiol 2000;151:251-8.
96. Mustonen TK, Spencer SM, Hoskinson RA, Sachs DP, Garvey AJ. The influence of gender, race, and menthol content on tobacco exposure measures. Nicotine Tob Res 2005;7:581-90.
97. Epstein LH, Dickson BE, Ossip DJ, et al. Relationships among measures of smoking topography. Addict Behav 1982;7:307-10.
98. Wood T, Wewers ME, Groner J, Ahijevych K. Smoke constituent exposure and smoking topography of adolescent daily cigarette smokers. Nicotine Tob Res 2004;6:853-62.
99. Ahijevych K, Parsley LA. Smoke constituent exposure and stage of change in black and white women cigarette smokers. Addict Behav 1999;24:115-20.
100. Lombardo T, Carreno L. Relationship of type A behavior pattern in smokers to carbon monoxide exposure and smoking topography. Health Psychol 1987;6:445-52.
101. Hatsukami DK, Morgan SF, Pickens RW, Champagne SE. Situational factors in cigarette smoking. Addict Behav 1990;15:1-12.
102. Morgan SF, Gust SW, Pickens RW, Champagne SE, Hughes JR. Temporal patterns of smoking topography in the natural environment. Int J Addict 1985;20:613-21.
103. Herning RI, Jones RT, Benowitz NL, Mines AH. How a cigarette is smoked determines blood nicotine levels. Clin Pharmacol Ther 1983; 33:84-90.
104. Bridges RB, Combs JG, Humble JW, et al. Puffing topography as a determinant of smoke exposure. Pharmacol Biochem Behav 1990;37: 29-39.
105. Kolonen S, Tuomisto J, Puustinen P, Airaksinen MM. Puffing behavior during the smoking of a single cigarette in a naturalistic environment. Pharmacol Biochem Behav 1992;41:701-6.
106. Lichtenstein E, Antonuccio DO. Dimensions of smoking behavior. Addict Behav 1981;6:365-7.
107. Burling TA, Stitzer ML, Bigelow GE, Mead AM. Smoking topography and carbon monoxide levels in smokers. Addict Behav 1985;10: 319-23.
108. Humble JW, Turbek JA, Rehm SR. Smoking history, cigarette yield and smoking behavior as determinants of smoke exposure. Eur J Respir Dis Suppl 1986;146:129-37.
109. Djordjevic MV, Stellman SD, Zang E. Doses of nicotine and lung carcinogens delivered to cigarette smokers. J Natl Cancer Inst 2000;92: 106-11.
110. Scherer G. Smoking behaviour and compensation: a review of the literature. Psychopharmacology (Berl) 1999;145:1-20.
111. Buzzi R, Nil R, Battig K. Development of puffing behavior along burning time of a cigarette-no relation to alveolar inhalation or nicotine delivery of the cigarettes? Psychopharmacology (Berl) 1985;86: 102-7.
112. Rieben FW. Smoking behaviour and increase in nicotine and carboxyhaemoglobin in venous blood. Clin Investig 1992;70:335-42.
113. Zacny JP, Stitzer ML, Yingling JE. Cigarette filter vent blocking: effects on smoking topography and carbon monoxide exposure. Pharmacol Biochem Behav 1986;25:1245-52.
114. Weinhold LL, Stitzer ML. Effects of puff number and puff spacing on carbon monoxide exposure from commercial brand cigarettes. Pharmacol Biochem Behav 1989;33:853-8.
115. Strasser AA, Lerman C, Sanborn PM, Pickworth WB, Feldman EA. New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposure. Drug Alcohol Depend 2007;86:294-300.
116. Sweeney CT, Kozlowski LT. Blocking filter vents increases carbon monoxide levels from ultralight, but not light cigarettes. Pharmacol Biochem Behav 1998;59:767-73.
117. Strasser AA, Ashare RL, Kozlowski LT, Pickworth WB. The effect of filter vent blocking and smoking topography on carbon monoxide levels in smokers. Pharmacol Biochem Behav 2005;82:320-9.
118. Kolonen S, Tuomisto J, Puustinen P, Airaksinen MM. Smoking behavior in low-yield cigarette smokers and switchers in the natural environment. Pharmacol Biochem Behav 1991;40:177-80.
119. Stepney R.Would a medium-nicotine, low-tar cigarette be less hazardous to health? Br Med J (Clin Res Ed) 1981;283:1292-6.
120. Russell MA, Sutton SR, Iyer R, Feyerabend C, Vesey CJ. Long-term switching to low-tar low-nicotine cigarettes. Br J Addict 1982;77: 145-58.
121. Ossip-Klein DJ, Epstein LH, Winter MK, et al. Does switching to low tar/nicotine/carbon monoxide-yield cigarettes decrease alveolar carbon monoxide measures? A randomized controlled trial. J Consult Clin Psychol 1983;51:234-41.
122. Nil R, Buzzi R, Battig K. Effects of different cigarette smoke yields on puffing and inhalation: is the measurement of inhalation volumes relevant for smoke absorption? Pharmacol Biochem Behav 1986;24:587-95.
123. Armitage AK, Alexander J, Hopkins R, Ward C. Evaluation of a low to middle tar/medium nicotine cigarette designed to maintain nicotine delivery to the smoker. Psychopharmacology (Berl) 1988;96:447-53.
124. Zacny JP, Stitzer ML. Cigarette brand-switching: effects on smoke exposure and smoking behavior. J Pharmacol Exp Ther 1988;246: 619-27.
125. Nil R, Battig K. Separate effects of cigarette smoke yield and smoke taste on smoking behavior. Psychopharmacology (Berl) 1989;99:54-9.
126. Baldinger B, Hasenfratz M, Battig K. Switching to ultralow nicotine cigarettes: effects of different tar yields and blocking of olfactory cues. Pharmacol Biochem Behav 1995;50:233-9.
127. Herning RI, Jones RT, Bachman J, Mines AH. Puff volume increases when low-nicotine cigarettes are smoked. Br Med J (Clin Res Ed) 1981;283:187-9.
128. Tobin MJ, Sackner MA. Monitoring smoking patterns of low and high tar cigarettes with inductive plethysmography. Am Rev Respir Dis 1982;126:258-64.
129. McBride MJ, Guyatt AR, Kirkham AJ, Cumming G. Assessment of smoking behaviour and ventilation with cigarettes of differing nicotine yields. Clin Sci (Lond) 1984;67:619-31.
130. Gust SW, Pickens RW. Does cigarette nicotine yield affect puff volume? Clin Pharmacol Ther 1982;32:418-22.
131. Woodman G, Newman SP, Pavia D, Clarke SW. The separate effects of tar and nicotine on the cigarette smoking manoeuvre. Eur J Respir Dis 1987;70:316-21.
132. Woodman G, Newman SP, Pavia D, Clarke SW. Inhaled smoke volume and puff indices with cigarettes of different tar and nicotine levels. Eur J Respir Dis 1987;70:187-92.
133. Benowitz NL, Jacob P, III, Bernert JT, et al. Carcinogen exposure during short-term switching from regular to "light" cigarettes. Cancer Epidemiol Biomarkers Prev 2005;14:1376-83.
134. Sweeney CT, Kozlowski LT, Parsa P. Effect of filter vent blocking on carbon monoxide exposure from selected lower tar cigarette brands. Pharmacol Biochem Behav 1999;63:167-73.
135. Wayne GF, Thomas BF, Connolly GN. Physical design analysis and mainstream smoke constituent yields of the new potential reduced exposure product, Marlboro UltraSmooth. Nicotine Tob Res 2007;9: 1197-206.
136. Breland AB, Acosta MC, Eissenberg T. Tobacco specific nitrosamines and potential reduced exposure products for smokers: a preliminary evaluation of Advance. Tob Control 2003;12:317-21.
137. Breland AB, Evans SE, Buchhalter AR, Eissenberg T. Acute effects of Advance: a potential reduced exposure product for smokers. Tob Control 2002;11:376-8.
138. Breland AB, Kleykamp BA, Eissenberg T. Clinical laboratory evaluation of potential reduced exposure products for smokers. Nicotine Tob Res 2006;8:727-38.
139. Slade J, Connolly GN, Lymperis D. Eclipse: does it live up to its health claims? Tob Control 2002;11 Suppl 2:ii64-70.
140. Lee EM, Malson JL, Moolchan ET, Pickworth WB. Quantitative comparisons between a nicotine delivery device (Eclipse) and conventional cigarette smoking. Nicotine Tob Res 2004;6:95-102.
141. Hatsukami DK, Benowitz NL, Rennard SI, Oncken C, Hecht SS. Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine Tob Res 2006;8:600-22.
142. Tobin MJ, Jenouri G, Sackner MA. Subjective and objective measurement of cigarette smoke inhalation. Chest 1982;82:696-700.
143. Sackner J, Nixon A, Davis B, Atkins N, Sackner M. Non-invasive measurement of ventilation during exercise using a respiratory inductive plethysmograph. I. Am Rev Respir Dis 1980;122:867-71.
144. Chadha TS, Watson H, Birch S, et al. Validation of respiratory inductive plethysmography using different calibration procedures. Am Rev Respir Dis 1982;125:644-9.
145. Charles FK, Krautter GR, Mariner DC. Post-puff respiration measures on smokers of different tar yield cigarettes. Inhal Toxicol 2009:1-7.
146. Armitage AK, Dixon M, Frost DE, Mariner DC, Sinclair NM. The effect of inhalation volume and breath-hold duration on the retention of nicotine and solanesol in the human respiratory tract and on subsequent plasma nicotine concentrations during cigarette smoking. Contributions to Tobacco Research 2004;21:240-9.
147. Feng S, Plunkett SE, Lam K, et al. A new method for estimating the retention of selected smoke constituents in the respiratory tract of smokers during cigarette smoking. Inhal Toxicol 2007;19:169-79.
148. Rickert WS, Robinson JC, Collishaw NE, Bray DF. Estimating the hazards of "less hazardous" cigarettes. III. A study of the effect of various smoking conditions on yields of hydrogen cyanide and cigarette tar. J Toxicol Environ Health 1983;12:39-54.
149. International Organization for Standardization-Ad Hoc Smoking Behavior Review Team Working Group 9 of the ISO TC 126. A review of human smoking behavior data and recommendations for a new ISO standard for the machine smoking of cigarettes. 2005.
150. Kozlowski LT. Application of some physical indicators of cigarette smoking. Addict Behav 1981;6:213-9.
151. Kozlowski LTOR, Sweeney C. Cigarette design. Smoking and Tobacco Control Monograph No. 13: Risks Associated with Smoking Cigarettes with Low Machine-Measured Yields of Tar and Nicotine. pp. 13-37Bethesda, MD: National Cancer Institute; 2001, Ref Type: Serial (Book Monograph).
152. Harris JE. Smoke yields of tobacco-specific nitrosamines in relation to FTC tar level and cigarette manufacturer: analysis of the Massachusetts Benchmark Study. Public Health Rep 2001;116:336-43.
153. Rickert WS. Determination of Cigarette Yields under Realistic Conditions. 1996, Ref Type: Generic.
154. Schorp MK. Summary of Literature Data on Smoking Topography. In: A review of human smoking behavior data and recommendations for a new ISO standard for the machine smoking of cigarettes. 2005.
155. Hammond D, O'Connor RJ. Constituents in tobacco and smoke emissions from Canadian cigarettes. Tob Control 2008;17 Suppl 1:i24-31.
156. Rickert WS, Trivedi AH, Momin RA, Wright WG, Lauterbach JH. Effect of smoking conditions and methods of collection on the mutagenicity and cytotoxicity of cigarette mainstream smoke. Toxicol Sci 2007;96:285-93.
157. Counts ME, Morton MJ, Laffoon SW, Cox RH, Lipowicz PJ. Smoke composition and predicting relationships for international commercial cigarettes smoked with three machine-smoking conditions. Regul Toxicol Pharmacol 2005;41:185-227.
158. Roemer E, Stabbert R, Rustemeier K, et al. Chemical composition, cytotoxicity and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions. Toxicology 2004;195:31-52.
159. Harris JE. Incomplete compensation does not imply reduced harm: yields of 40 smoke toxicants per milligram nicotine in regular filter versus low-tar cigarettes in the 1999 Massachusetts Benchmark Study. Nicotine Tob Res 2004;6:797-807.
160. Urban HJ, Gomm W, Schorp M. A modelling approach to develop machine smoking protocols reflecting human puffing behaviour for conventional cigarettes. Contributions to Tobacco Research 2008;23: 8-18.
161. Strasser AA, Pickworth WB, Patterson F, Lerman C. Smoking topography predicts abstinence following treatment with nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev 2004;13: 1800-4.
162. Lerman C, Wileyto EP, Patterson F, et al. The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial. Pharmacogenomics J 2004;4:184-92.
163. Lerman C, Shields PG, Wileyto EP, et al. Pharmacogenetic investigation of smoking cessation treatment. Pharmacogen 2002;12:627-34.
164. Lerman C, Berrettini W. Elucidating the role of genetic factors in smoking behavior and nicotine dependence. Am J Med Genet 2003; 118B:48-54.
165. Lerman C, Caporaso NE, Main D, et al. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol 1999; 18:14-20.
166. Ring HZ, Valdes AM, Nishita DM, et al. Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism. Pharmacogenet Genomics 2007;17:1007-15.
167. Mwenifumbo JC, Tyndale RF. Genetic variability in CYP2A6 and the pharmacokinetics of nicotine. Pharmacogenomics 2007;8:1385-402.
168. Benowitz NL, Swan GE, Jacob P, III, Lessov-Schlaggar CN, Tyndale RF. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine. Clin Pharmacol Ther 2006;80:457-67.
169. Malaiyandi V, Goodz SD, Sellers EM, Tyndale RF. CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking. Cancer Epidemiol Biomarkers Prev 2006;15: 1812-9.
170. Guillerm R, Radziszewski E. A new method of analyzing the act of smoking. Ann Tabac Etudes L'Equiment 1975;13:101-10.
171. Rawbone RC, Murphy K, Tate ME. The analysis of smoking patterns. In: Thornton RE, editor. Smoking Behaviour. London: Churchill Livingstone; 1978, p. 171-94.
172. Sackner MA. Monitoring of ventilation without a physical connection to the airway. In: Sackner MA, editor. Diagnostic techniques in pulmonary disease. Pat 1. New-York: Marcel Dekker; 1980, p. 503-37.